Although it is unlikely that mock demonstrators will be seen at any drug information or regulatory conferences, pharmacovigilance software is indeed having its “Salesforce” moment.
Jim Davis
Advertisement
Articles by Jim Davis
Advertisement
Latest Updated Articles
Pharmacovigilance Software's “Salesforce” MomentNovember 12th 2018
Advertisement
Advertisement
Trending on PharmExec
1
Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals
2
Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-PNPLA3
3
From Insight to Impact: Making Real-World Evidence Actionable in Urology
4
Pharmaceutical Executive Daily: Zentalis Doses First Patient with Azenosertib in Phase III Trial
5